163 related articles for article (PubMed ID: 38183597)
1. Efficacy of High-dose Liraglutide 3.0 mg in Patients with Poor Response to Bariatric Surgery: Real-world Experience and Updated Meta-analysis.
Vinciguerra F; Di Stefano C; Baratta R; Pulvirenti A; Mastrandrea G; Piazza L; Guccione F; Navarra G; Frittitta L
Obes Surg; 2024 Feb; 34(2):303-309. PubMed ID: 38183597
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and Safety of Liraglutide in Managing Inadequate Weight Loss and Weight Regain after Primary and Revisional Bariatric Surgery: Anthropometric and Cardiometabolic Outcomes.
Elhag W; El Ansari W
Obes Surg; 2022 Apr; 32(4):1005-1015. PubMed ID: 35060021
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery.
Muratori F; Vignati F; Di Sacco G; Gavazzi L; Pellegrino D; Del Prete M
Eat Weight Disord; 2022 Oct; 27(7):2775-2781. PubMed ID: 35763245
[TBL] [Abstract][Full Text] [Related]
4. Revisional Surgery or Pharmacotherapy for Insufficient Weight Loss and Weight Regain After Primary Bariatric Procedure: a Descriptive Study.
Dharmaratnam VM; Lim E; Eng A; Chan WH; Tan HC; Ho E; Kovalik JP; Ganguly S; Tan J; Lee PC; Lim CH
Obes Surg; 2022 Oct; 32(10):3298-3304. PubMed ID: 35994181
[TBL] [Abstract][Full Text] [Related]
5. High-dose liraglutide improves metabolic syndrome in poor responders to bariatric surgery.
Vinciguerra F; Piazza L; Di Stefano C; Degano C; Pulvirenti A; Baratta R; Frittitta L
Front Nutr; 2023; 10():1183899. PubMed ID: 37771756
[TBL] [Abstract][Full Text] [Related]
6. The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery-a Retrospective Analysis.
Lautenbach A; Wernecke M; Huber TB; Stoll F; Wagner J; Meyhöfer SM; Meyhöfer S; Aberle J
Obes Surg; 2022 Oct; 32(10):3280-3288. PubMed ID: 35879524
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.
Jensen AB; Renström F; Aczél S; Folie P; Biraima-Steinemann M; Beuschlein F; Bilz S
Obes Surg; 2023 Apr; 33(4):1017-1025. PubMed ID: 36765019
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of High-Dose Liraglutide as an Adjunct for Weight Loss in Patients with Prior Bariatric Surgery.
Rye P; Modi R; Cawsey S; Sharma AM
Obes Surg; 2018 Nov; 28(11):3553-3558. PubMed ID: 30022424
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-Like Peptide-1 Receptor Agonists in Post-bariatric Surgery Patients: A Systematic Review and Meta-analysis.
Dutta D; Nagendra L; Joshi A; Krishnasamy S; Sharma M; Parajuli N
Obes Surg; 2024 May; 34(5):1653-1664. PubMed ID: 38502519
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide 3.0 mg (Saxenda©) for Weight Loss and Remission of Pre-Diabetes. Real-World Clinical Evaluation of Effectiveness among Patients Awaiting Bariatric Surgery.
Wilmington R; Ardavani A; Simenacz A; Green C; Idris I
Obes Surg; 2024 Jan; 34(1):286-289. PubMed ID: 38012508
[TBL] [Abstract][Full Text] [Related]
11. Weight Regain and Insufficient Weight Loss After Bariatric Surgery: Definitions, Prevalence, Mechanisms, Predictors, Prevention and Management Strategies, and Knowledge Gaps-a Scoping Review.
El Ansari W; Elhag W
Obes Surg; 2021 Apr; 31(4):1755-1766. PubMed ID: 33555451
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery: The BARI-OPTIMISE Randomized Clinical Trial.
Mok J; Adeleke MO; Brown A; Magee CG; Firman C; Makahamadze C; Jassil FC; Marvasti P; Carnemolla A; Devalia K; Fakih N; Elkalaawy M; Pucci A; Jenkinson A; Adamo M; Omar RZ; Batterham RL; Makaronidis J
JAMA Surg; 2023 Oct; 158(10):1003-1011. PubMed ID: 37494014
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of bariatric surgery versus liraglutide in patients with type 2 diabetes and severe obesity: a 12-month retrospective evaluation.
Cotugno M; Nosso G; Saldalamacchia G; Vitagliano G; Griffo E; Lupoli R; Angrisani L; Riccardi G; Capaldo B
Acta Diabetol; 2015 Apr; 52(2):331-6. PubMed ID: 25218924
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and tolerability of liraglutide in patients with type 2 diabetes mellitus and obesity after bariatric surgery.
Gorgojo-Martínez JJ; Feo-Ortega G; Serrano-Moreno C
Surg Obes Relat Dis; 2016 Dec; 12(10):1856-1863. PubMed ID: 27256860
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of semaglutide versus liraglutide for treating post-metabolic and bariatric surgery weight recurrence.
Murvelashvili N; Xie L; Schellinger JN; Mathew MS; Marroquin EM; Lingvay I; Messiah SE; Almandoz JP
Obesity (Silver Spring); 2023 May; 31(5):1280-1289. PubMed ID: 36998152
[TBL] [Abstract][Full Text] [Related]
16. Routine clinical use of liraglutide 3 mg for the treatment of obesity: Outcomes in non-surgical and bariatric surgery patients.
Suliman M; Buckley A; Al Tikriti A; Tan T; le Roux CW; Lessan N; Barakat M
Diabetes Obes Metab; 2019 Jun; 21(6):1498-1501. PubMed ID: 30768836
[TBL] [Abstract][Full Text] [Related]
17. Short-term use of liraglutide in the management of patients with weight regain after bariatric surgery.
Pajecki D; Halpern A; Cercato C; Mancini M; de Cleva R; Santo MA
Rev Col Bras Cir; 2013; 40(3):191-5. PubMed ID: 23912365
[TBL] [Abstract][Full Text] [Related]
18. Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post-bariatric surgery.
Wharton S; Kuk JL; Luszczynski M; Kamran E; Christensen RAG
Clin Obes; 2019 Aug; 9(4):e12323. PubMed ID: 31183988
[TBL] [Abstract][Full Text] [Related]
19. Long-term weight outcomes in patients treated with liraglutide 3.0 mg in real-world clinical practice.
Grannell A; Al-Najim W; le Roux C
Clin Obes; 2024 Feb; 14(1):e12622. PubMed ID: 37615384
[TBL] [Abstract][Full Text] [Related]
20. Use of Weight Loss Medications in Patients after Bariatric Surgery.
Redmond IP; Shukla AP; Aronne LJ
Curr Obes Rep; 2021 Jun; 10(2):81-89. PubMed ID: 33492629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
